Prestige Wealth Management Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34.3K | Hold |
77
| – | – | 0.01% | 292 |
|
|
2025
Q1 | $37.3K | Sell |
77
-35
| -31% | -$17K | 0.01% | 283 |
|
|
2024
Q4 | $45.1K | Buy |
112
+35
| +45% | +$14.1K | 0.01% | 266 |
|
|
2024
Q3 | $35.8K | Hold |
77
| – | – | 0.01% | 278 |
|
|
2024
Q2 | $36.1K | Sell |
77
-15
| -16% | -$7.03K | 0.01% | 251 |
|
|
2024
Q1 | $38.5K | Sell |
92
-11
| -11% | -$4.6K | 0.01% | 276 |
|
|
2023
Q4 | $41.9K | Sell |
103
-6
| -6% | -$2.44K | 0.01% | 258 |
|
|
2023
Q3 | $37.9K | Hold |
109
| – | – | 0.01% | 264 |
|
|
2023
Q2 | $38.4K | Sell |
109
-4
| -4% | -$1.41K | 0.01% | 285 |
|
|
2023
Q1 | $35.6K | Sell |
113
-6
| -5% | -$1.89K | 0.01% | 267 |
|
|
2022
Q4 | $34.4K | Sell |
119
-721
| -86% | -$208K | 0.01% | 287 |
|
|
2022
Q3 | $244K | Buy |
840
+637
| +314% | +$185K | 0.07% | 124 |
|
|
2022
Q2 | $57K | Sell |
203
-5
| -2% | -$1.4K | 0.02% | 226 |
|
|
2022
Q1 | $54K | Buy |
208
+2
| +1% | +$519 | 0.01% | 237 |
|
|
2021
Q4 | $46K | Buy |
206
+57
| +38% | +$12.7K | 0.01% | 273 |
|
|
2021
Q3 | $27K | Sell |
149
-2
| -1% | -$362 | 0.01% | 328 |
|
|
2021
Q2 | $30K | Sell |
151
-9
| -6% | -$1.79K | 0.01% | 302 |
|
|
2021
Q1 | $34K | Buy |
160
+12
| +8% | +$2.55K | 0.01% | 287 |
|
|
2020
Q4 | $35K | Sell |
148
-57
| -28% | -$13.5K | 0.01% | 283 |
|
|
2020
Q3 | $55K | Buy |
205
+13
| +7% | +$3.49K | 0.02% | 242 |
|
|
2020
Q2 | $55K | Buy |
192
+152
| +380% | +$43.5K | 0.02% | 213 |
|
|
2020
Q1 | $10K | Buy |
+40
| New | +$10K | ﹤0.01% | 388 |
|
|
2019
Q4 | – | Sell |
-2
| Closed | – | – | 681 |
|
|
2019
Q3 | $0 | Buy |
+2
| New | – | ﹤0.01% | 646 |
|
|
2019
Q1 | – | Sell |
-125
| Closed | -$21K | – | 1128 |
|
|
2018
Q4 | $21K | Buy |
+125
| New | +$21K | 0.02% | 302 |
|